Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. / Karuna, Ratna; Holleboom, Adriaan G; Motazacker, Mohammad M; Kuivenhoven, Jan Albert; Frikke-Schmidt, Ruth; Tybjaerg-Hansen, Anne; Georgopoulos, Spiros; van Eck, Miranda; van Berkel, Theo J C; von Eckardstein, Arnold; Rentsch, Katharina M.

In: Atherosclerosis, Vol. 214, No. 2, 01.02.2011, p. 448-55.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Karuna, R, Holleboom, AG, Motazacker, MM, Kuivenhoven, JA, Frikke-Schmidt, R, Tybjaerg-Hansen, A, Georgopoulos, S, van Eck, M, van Berkel, TJC, von Eckardstein, A & Rentsch, KM 2011, 'Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism', Atherosclerosis, vol. 214, no. 2, pp. 448-55. https://doi.org/10.1016/j.atherosclerosis.2010.10.042, https://doi.org/10.1016/j.atherosclerosis.2010.10.042

APA

Karuna, R., Holleboom, A. G., Motazacker, M. M., Kuivenhoven, J. A., Frikke-Schmidt, R., Tybjaerg-Hansen, A., Georgopoulos, S., van Eck, M., van Berkel, T. J. C., von Eckardstein, A., & Rentsch, K. M. (2011). Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. Atherosclerosis, 214(2), 448-55. https://doi.org/10.1016/j.atherosclerosis.2010.10.042, https://doi.org/10.1016/j.atherosclerosis.2010.10.042

Vancouver

Karuna R, Holleboom AG, Motazacker MM, Kuivenhoven JA, Frikke-Schmidt R, Tybjaerg-Hansen A et al. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. Atherosclerosis. 2011 Feb 1;214(2):448-55. https://doi.org/10.1016/j.atherosclerosis.2010.10.042, https://doi.org/10.1016/j.atherosclerosis.2010.10.042

Author

Karuna, Ratna ; Holleboom, Adriaan G ; Motazacker, Mohammad M ; Kuivenhoven, Jan Albert ; Frikke-Schmidt, Ruth ; Tybjaerg-Hansen, Anne ; Georgopoulos, Spiros ; van Eck, Miranda ; van Berkel, Theo J C ; von Eckardstein, Arnold ; Rentsch, Katharina M. / Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. In: Atherosclerosis. 2011 ; Vol. 214, No. 2. pp. 448-55.

Bibtex

@article{dc25a639502a45f88d3764d5c267cd49,
title = "Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism",
abstract = "Secretion of 27-hydroxycholesterol (27OHC) from macrophages is considered as an alternative to HDL-mediated reverse transport of excess cholesterol. We investigated 27OHC-concentrations in plasma of humans and mice with monogenic disorders of HDL metabolism. As compared to family controls mutations in the genes for apolipoprotein A-I, ATP binding cassette transporter (ABC) A1 and lecithin:cholesterol acylstransferase (LCAT) were associated with reduced concentrations of both HDL-cholesterol and HDL-27OHC whereas mutations in the genes for cholesterylester transfer protein (CETP), scavenger receptor type BI and hepatic lipase were associated with elevated HDL concentrations of either sterol. Compared to family controls and relative to the concentrations of total 27OHC and cholesterol, lower 27OHC-ester but normal cholesterylester levels were found in HDL of heterozygous LCAT mutation carriers and nonHDL of heterozygous CETP mutation carriers. In family controls, LCAT activity and CETP mass were more strongly correlated with 27OHC-ester than cholesterylester concentrations in HDL and nonHDL, respectively. These findings suggest that the formation and transfer of 27OHC-esters are more sensitive to reduced activities of LCAT and CETP, respectively, than the formation and transfer of cholesterylesters. 27OHC plasma levels were also decreased in apoA-I-, ABCA1- or LCAT-knockout mice but increased in SR-BI-knockout mice. Transplantation of ABCA1- and/or ABCG1-deficient bone marrow into LDL receptor deficient mice decreased plasma levels of 27OHC. In conclusion, mutations or absence of HDL genes lead to distinct alterations in the quantity, esterification or lipoprotein distribution of 27OHC. These findings argue against the earlier suggestion that 27OHC-metabolism in plasma occurs independently of HDL.",
author = "Ratna Karuna and Holleboom, {Adriaan G} and Motazacker, {Mohammad M} and Kuivenhoven, {Jan Albert} and Ruth Frikke-Schmidt and Anne Tybjaerg-Hansen and Spiros Georgopoulos and {van Eck}, Miranda and {van Berkel}, {Theo J C} and {von Eckardstein}, Arnold and Rentsch, {Katharina M}",
note = "Copyright {\textcopyright} 2010 Elsevier Ireland Ltd. All rights reserved.",
year = "2011",
month = feb,
day = "1",
doi = "10.1016/j.atherosclerosis.2010.10.042",
language = "English",
volume = "214",
pages = "448--55",
journal = "Atherosclerosis",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

RIS

TY - JOUR

T1 - Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism

AU - Karuna, Ratna

AU - Holleboom, Adriaan G

AU - Motazacker, Mohammad M

AU - Kuivenhoven, Jan Albert

AU - Frikke-Schmidt, Ruth

AU - Tybjaerg-Hansen, Anne

AU - Georgopoulos, Spiros

AU - van Eck, Miranda

AU - van Berkel, Theo J C

AU - von Eckardstein, Arnold

AU - Rentsch, Katharina M

N1 - Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

PY - 2011/2/1

Y1 - 2011/2/1

N2 - Secretion of 27-hydroxycholesterol (27OHC) from macrophages is considered as an alternative to HDL-mediated reverse transport of excess cholesterol. We investigated 27OHC-concentrations in plasma of humans and mice with monogenic disorders of HDL metabolism. As compared to family controls mutations in the genes for apolipoprotein A-I, ATP binding cassette transporter (ABC) A1 and lecithin:cholesterol acylstransferase (LCAT) were associated with reduced concentrations of both HDL-cholesterol and HDL-27OHC whereas mutations in the genes for cholesterylester transfer protein (CETP), scavenger receptor type BI and hepatic lipase were associated with elevated HDL concentrations of either sterol. Compared to family controls and relative to the concentrations of total 27OHC and cholesterol, lower 27OHC-ester but normal cholesterylester levels were found in HDL of heterozygous LCAT mutation carriers and nonHDL of heterozygous CETP mutation carriers. In family controls, LCAT activity and CETP mass were more strongly correlated with 27OHC-ester than cholesterylester concentrations in HDL and nonHDL, respectively. These findings suggest that the formation and transfer of 27OHC-esters are more sensitive to reduced activities of LCAT and CETP, respectively, than the formation and transfer of cholesterylesters. 27OHC plasma levels were also decreased in apoA-I-, ABCA1- or LCAT-knockout mice but increased in SR-BI-knockout mice. Transplantation of ABCA1- and/or ABCG1-deficient bone marrow into LDL receptor deficient mice decreased plasma levels of 27OHC. In conclusion, mutations or absence of HDL genes lead to distinct alterations in the quantity, esterification or lipoprotein distribution of 27OHC. These findings argue against the earlier suggestion that 27OHC-metabolism in plasma occurs independently of HDL.

AB - Secretion of 27-hydroxycholesterol (27OHC) from macrophages is considered as an alternative to HDL-mediated reverse transport of excess cholesterol. We investigated 27OHC-concentrations in plasma of humans and mice with monogenic disorders of HDL metabolism. As compared to family controls mutations in the genes for apolipoprotein A-I, ATP binding cassette transporter (ABC) A1 and lecithin:cholesterol acylstransferase (LCAT) were associated with reduced concentrations of both HDL-cholesterol and HDL-27OHC whereas mutations in the genes for cholesterylester transfer protein (CETP), scavenger receptor type BI and hepatic lipase were associated with elevated HDL concentrations of either sterol. Compared to family controls and relative to the concentrations of total 27OHC and cholesterol, lower 27OHC-ester but normal cholesterylester levels were found in HDL of heterozygous LCAT mutation carriers and nonHDL of heterozygous CETP mutation carriers. In family controls, LCAT activity and CETP mass were more strongly correlated with 27OHC-ester than cholesterylester concentrations in HDL and nonHDL, respectively. These findings suggest that the formation and transfer of 27OHC-esters are more sensitive to reduced activities of LCAT and CETP, respectively, than the formation and transfer of cholesterylesters. 27OHC plasma levels were also decreased in apoA-I-, ABCA1- or LCAT-knockout mice but increased in SR-BI-knockout mice. Transplantation of ABCA1- and/or ABCG1-deficient bone marrow into LDL receptor deficient mice decreased plasma levels of 27OHC. In conclusion, mutations or absence of HDL genes lead to distinct alterations in the quantity, esterification or lipoprotein distribution of 27OHC. These findings argue against the earlier suggestion that 27OHC-metabolism in plasma occurs independently of HDL.

U2 - 10.1016/j.atherosclerosis.2010.10.042

DO - 10.1016/j.atherosclerosis.2010.10.042

M3 - Journal article

C2 - 21130455

VL - 214

SP - 448

EP - 455

JO - Atherosclerosis

JF - Atherosclerosis

SN - 0021-9150

IS - 2

ER -

ID: 34151789